Hence, interfering with SOX2 nuclear translocation by small molecules able to antagonize SOX2-importin interaction may provide an additional therapy perspective for glioblastoma, and possibly other SOX2-dependent tumors. The gene discussed is SOX2; the disease is glioblastoma.